• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Viasys Healthcare

Viasys Healthcare

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. MetLife VAs flounder as Fidelity halts sales

    The insurer's variable annuities dipped 39% year-over-year in the second quarter, offering a glimpse into the power of big distributors like Fidelity.

  2. Finra targets variable annuities as 'sweet spot' of scrutiny

    Following record MetLife fine, regulator says VAs are now at the core of their focus: complex products marketed to seniors.

  3. Fixed indexed annuity sales gaining on VAs : Cerulli

    Fixed indexed annuity sales are steadily gaining on those of variable annuities, thanks in large part to continued low interest rates.

  4. Jackson National to offer DoubleLine smart beta fund in VAs

    Smart-beta strategies got their latest seal of approval in the form of a $100 million mandate from variable annuity giant Jackson National, which has added the DoubleLine Shiller Enhanced CAPE Fund to its menu of VA investment options.

  5. What Advisors Don’t Know About Variable Annuities: How VAs Fit Into a Client’s Portfolio

    Properly assessing the viability of a variable annuity for a particular client entails considerably more than just adding it alongside a standard model portfolio.

  6. Perez calls out variable annuities in argument for DOL fiduciary rule

    Using an anecdote critical of VAs , Thomas Perez says most people are better served by simple investments.

  7. Jackson National's variable annuity sales suspensions pay off

    Advisers willing to wait to get into the carrier's VAs and if history is any guide, first quarter sales will jump.

Upcoming Events

©2014 Morningstar Advisor. All right reserved.